Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Lymphoma 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lung Neoplasms 2Hematologic Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Squamous Cell Cancers of the Head and Neck 1Skin Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1NSCLC Harboring NRG1 Fusion 1Mouth Neoplasms 1Glioma 1Fanconi Anemia 1Endometrial Neoplasms 1Cholangiocarcinoma 1

Interventions

Prednisone 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Squamous Non Small Cell Lung Cancer × Afatinib × 1 year × Clear all
NCT04497584 2025-10-01

Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC

University of Texas Southwestern Medical Center

Phase 2 Active not recruiting
12 enrolled
Thoracic

Advanced Squamous Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡